- Home
- IRON vs NXRT Comparison
IRON vs NXRT Comparison
Compare IRON & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- NXRT
- Stock Information
- Founded
- IRON 2017
- NXRT 2014
- Country
- IRON United States
- NXRT United States
- Employees
- IRON N/A
- NXRT N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- NXRT Real Estate Investment Trusts
- Sector
- IRON Health Care
- NXRT Real Estate
- Exchange
- IRON Nasdaq
- NXRT Nasdaq
- Market Cap
- IRON 1.9B
- NXRT 1.2B
- IPO Year
- IRON N/A
- NXRT N/A
- Fundamental
- Price
- IRON $57.83
- NXRT $38.91
- Analyst Decision
- IRON Strong Buy
- NXRT Buy
- Analyst Count
- IRON 10
- NXRT 5
- Target Price
- IRON $73.70
- NXRT $49.00
- AVG Volume (30 Days)
- IRON 245.9K
- NXRT 140.8K
- Earning Date
- IRON 11-12-2024
- NXRT 02-18-2025
- Dividend Yield
- IRON N/A
- NXRT 5.28%
- EPS Growth
- IRON N/A
- NXRT 54.64
- EPS
- IRON N/A
- NXRT 1.77
- Revenue
- IRON N/A
- NXRT $264,974,000.00
- Revenue This Year
- IRON N/A
- NXRT N/A
- Revenue Next Year
- IRON N/A
- NXRT $0.15
- P/E Ratio
- IRON N/A
- NXRT $21.83
- Revenue Growth
- IRON N/A
- NXRT N/A
- 52 Week Low
- IRON $25.60
- NXRT $28.20
- 52 Week High
- IRON $77.60
- NXRT $48.37
- Technical
- Relative Strength Index (RSI)
- IRON 37.45
- NXRT 34.42
- Support Level
- IRON $57.09
- NXRT $37.24
- Resistance Level
- IRON $62.20
- NXRT $42.14
- Average True Range (ATR)
- IRON 2.88
- NXRT 0.91
- MACD
- IRON -0.82
- NXRT -0.30
- Stochastic Oscillator
- IRON 8.16
- NXRT 31.38
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.